What Is a REMS? Risk Evaluation and Mitigation Strategies
Updated
Quick answer
A REMS is a Risk Evaluation and Mitigation Strategy: an FDA-required safety program attached to a drug whose benefits only outweigh its risks when specific safeguards are in place. It can be as light as a Medication Guide handed out with every fill, or as restrictive as requiring a certified prescriber, a certified pharmacy, a patient registry, and a current lab result before a single tablet leaves the shelf. Technicians meet REMS constantly, because most of the operational steps fall to them.
Where REMS comes from
The FDA gained the authority to require a REMS under the Food and Drug Administration Amendments Act of 2007. Before that, the agency's realistic options for a drug with a serious risk were narrow: approve it with warnings, or refuse it. A REMS created a middle path, letting a drug reach the patients who need it while conditions are placed on how it is prescribed and dispensed.
That framing matters for the exam, because it explains why REMS drugs feel awkward to dispense. The friction is the point. Every extra step exists because FDA concluded the drug could not be approved safely without it. This sits alongside the other federal controls covered on the Federal Requirements hub, though note that REMS is an FDA program about drug safety, not a DEA program about controlled substances. Those two systems are separate, and confusing them is a common exam trap.
The five possible elements of a REMS
A REMS is assembled from the elements below. Most programs use only one or two, and only the most dangerous drugs carry the full set.
| Element | What it means |
|---|---|
| Medication Guide | FDA-approved patient handout explaining a specific serious risk, given every time the drug is dispensed. This is the most common REMS element and the one a technician handles most often. |
| Communication plan | Structured messaging from the manufacturer to healthcare providers, such as letters to prescribers and information sent to professional societies. |
| Elements to assure safe use (ETASU) | The restrictive tier. Used only where the risk is severe enough to justify limiting access. See the ETASU table below. |
| Implementation system | How the manufacturer monitors and enforces the ETASU across prescribers, pharmacies, and distributors. |
| Timetable for assessment | The schedule on which the manufacturer must report back to FDA on whether the REMS is working. |
ETASU: the restrictive tier
Elements to Assure Safe Use are the requirements that actually limit access, and they are the part of a REMS that changes a technician's workflow. FDA attaches them only when the risk is severe enough to justify making the drug harder to obtain.
| ETASU requirement | In practice |
|---|---|
| Prescriber certification | The prescriber must be specially certified or trained before they can write for the drug. |
| Pharmacy or dispenser certification | The pharmacy itself must enroll and be certified before it can dispense. |
| Restricted settings | The drug can be dispensed only in certain healthcare settings, such as an infusion centre or hospital. |
| Documented safe-use conditions | Evidence of a required condition must exist before dispensing, such as a current lab result or a negative pregnancy test. |
| Patient monitoring | The patient must be monitored on a defined schedule while taking the drug. |
| Patient enrollment in a registry | The patient must be entered into a registry that tracks everyone receiving the drug. |
Drugs you are likely to be asked about
REMS programs change over time as FDA modifies or removes them, so treat any list as a snapshot and check the current FDA database for the live position. These are the examples that recur in exam material.
| Drug | Why it carries a REMS |
|---|---|
| Clozapine | Requires a current absolute neutrophil count before dispensing, because the drug can cause severe neutropenia. |
| Isotretinoin | Managed through the iPLEDGE program, with pregnancy testing and registry enrollment, because the drug causes severe birth defects. |
| Thalidomide, lenalidomide, pomalidomide | Registry enrollment and pregnancy prevention requirements for the same reason. |
| Mifepristone | Prescriber and pharmacy certification requirements. |
| Opioid analgesics | Prescriber education and Medication Guide requirements aimed at overdose and misuse risk. |
The clearest worked example is clozapine, which cannot be released without a current absolute neutrophil count on file. The pharmacology behind that requirement is covered in the PTCB Guide to Antipsychotics, and it is worth reading the two together: the REMS exists because of a specific adverse effect, and understanding the effect makes the requirement memorable rather than arbitrary.
What the technician actually does
- Confirm the pharmacy is certified for the program before accepting the prescription.
- Check that the prescriber and, where required, the patient are enrolled.
- Confirm the safe-use condition is documented and current, such as a lab value or an authorization number, before the fill proceeds.
- Obtain and attach the authorization number where the program issues one.
- Make sure the Medication Guide is dispensed with the drug every time.
- Escalate anything missing, expired, or inconsistent to the pharmacist rather than working around it.
The dividing line is the one that runs through the whole exam: technicians gather, verify, and document, and pharmacists exercise professional judgement. A technician who notices that a clozapine lab result is three weeks stale has done their job correctly by stopping and handing it over.
Frequently asked questions
What does REMS stand for?
Risk Evaluation and Mitigation Strategy. It is a drug safety program the FDA can require when a medication's benefits outweigh its risks only if specific safeguards are in place. The authority comes from the Food and Drug Administration Amendments Act of 2007.
What is the difference between a REMS and a Medication Guide?
A Medication Guide is one possible element of a REMS, not a separate system. Many drugs have a Medication Guide without any wider REMS attached. When a REMS exists, the Medication Guide may be its only requirement, or it may sit alongside far more restrictive elements such as prescriber certification and patient registries.
What does ETASU mean?
Elements to Assure Safe Use. These are the restrictive requirements FDA can attach to the highest-risk drugs: prescriber certification, pharmacy certification, restricted dispensing settings, documented safe-use conditions such as a current lab value, patient monitoring, and enrollment in a registry. A REMS only carries ETASU when the risk justifies limiting access.
What is the pharmacy technician's role in a REMS?
Technicians do the operational work: confirming the pharmacy is certified, checking that the patient and prescriber are enrolled where required, confirming a current lab result or authorization number is on file before the prescription is filled, and making sure the Medication Guide goes out with the drug. Any judgement call, and any decision about a prescription that does not meet the requirements, belongs to the pharmacist.
Can a prescription be filled if the REMS requirements are not met?
No. If a REMS requires a current lab result, a registry enrollment, or an authorization number and it is missing, the drug cannot be dispensed. This is not a matter of pharmacy policy: the restriction is a federal condition of the drug's approval, and dispensing without it puts both the patient and the pharmacy's certification at risk.
How do you find out whether a drug has a REMS?
FDA maintains a searchable database of approved REMS programs, linked in the sources below. Pharmacy software also flags REMS drugs at the point of entry, which in practice is where a technician usually encounters them first.
Test yourself
REMS questions sit in the Federal Requirements domain alongside controlled substance law and drug supply chain rules. Work them in context on the PTCB federal requirements quiz, and pair this page with the Drug Supply Chain Security Act, which governs a different part of the same regulatory picture: not who may receive a drug, but whether the product itself is legitimate.
Official sources
- FDA: Risk Evaluation and Mitigation Strategies (REMS)
- FDA: approved REMS database (searchable, current programs)
- MedlinePlus: Clozapine (the monitoring requirement in patient terms)
PTCB Quiz Prep is an independent study resource, not affiliated with the Pharmacy Technician Certification Board or the FDA. REMS programs are added, modified, and withdrawn over time, so confirm any specific program against the FDA database above before relying on it in practice. Part of the PTCB Federal Requirements domain.